Dual Antiplatelet Therapy Beyond One Year After Drug-eluting Coronary Stent Procedures Laura Mauri, Dean J. Kereiakes, Robert W. Yeh, Priscilla Driscoll-Shempp, Donald E. Cutlip, P. Gabriel Steg, Sharon-Lise T. Normand,

First Page		Document Content
Date: 2014-11-16 18:06:33 Aging-associated diseases Coronary stent Drug-eluting stent Aspirin Antiplatelet drug Stroke Stent Myocardial infarction Clopidogrel Medicine Interventional cardiology Implants		Dual Antiplatelet Therapy Beyond One Year After Drug-eluting Coronary Stent Procedures Laura Mauri, Dean J. Kereiakes, Robert W. Yeh, Priscilla Driscoll-Shempp, Donald E. Cutlip, P. Gabriel Steg, Sharon-Lise T. Normand, Add to Reading List Source URL: www.hcri.harvard.edu Download Document from Source Website File Size: 4,66 MB Share Document on Facebook

	Advanced Cardiovascular Stent Incorporated with a Nitric Oxide Delivery System Investigators: Hai-Lung Tsai (, ), Adam Hamdorf, Cheng-Hsiang Lin, Patrick Margavio, Chi H Lee (UMKC), Richard Hopki DocID: 1qd5n - View Document
	Médecine cardiovas culaire Kardiovaskuläre Medizin Supplementum 17 ad Médecine cardiovasculaire 2009;12(5) DocID: 1pXtk - View Document
	ABSORB STENT APPROVED FOR THE U.S. For people with coronary artery disease, Absorb offers something unique. While most stents are made of metal, Absorb is made of a naturally dissolvable material. It dissolves completely DocID: 1oym7 - View Document
	Mathematical challenges in controlled drug delivery J OSÉ AUGUSTO F ERREIRA CMUC , DEPARTMENT OF MATHEMATICS - UNIVERSITY OF COIMBRA DocID: 1oxR9 - View Document
	Curriculum Vitae James Michael Wilson, M.D. DocID: 1ou7k - View Document